The popularity of Sildenafil initially drove a boom for pharma, but recent shifts present a uncertain scenario for those considering a stake. Generic competitors are eating into revenue, and ongoing legal battles add https://tessmtos225844.alltdesign.com/sildenafil-and-big-pharma-a-volatile-bet-59905487